These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2347516)

  • 1. Effect of quinidine on platelets.
    Chong BH; Kaplin IJ
    Haemostasis; 1990; 20(2):106-11. PubMed ID: 2347516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of ferriprotoporphyrin IX on platelet aggregation and release of serotonin.
    Essien EM
    Thromb Res; 1985 Dec; 40(5):609-22. PubMed ID: 4089831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing susceptibilities of platelets from normal individuals and patients with von Willebrand's disease to attack by quinine- and quinidine-dependent antiplatelet antibodies.
    Pfueller SL; Bilston RA; Logan D; David R; Sloan IG; Firkin BG
    Thromb Haemost; 1989 Feb; 61(1):111-6. PubMed ID: 2787540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal anti-human platelet antibody: a new platelet aggregating substance.
    Higashihara M; Maeda H; Shibata Y; Kume S; Ohashi T
    Blood; 1985 Feb; 65(2):382-91. PubMed ID: 3967086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human platelet function by sulfatides.
    Devaiah AK; Raife TJ; Barton JA; Olson JD
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):543-50. PubMed ID: 10997794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of surface injury and shear stress on platelet aggregation and serotonin release.
    Johnston GG; Marzec U; Berstein EF
    Trans Am Soc Artif Intern Organs; 1975; 21():413-21. PubMed ID: 1146015
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative effects of quinidine and aspirin on bleeding time and platelet alpha 2-adrenoceptors: potential mechanism of bleeding diathesis in patients receiving this combination.
    Lawson D; Mehta J; Mehta P; Lipman BC; Imperi GA
    J Lab Clin Med; 1986 Dec; 108(6):581-6. PubMed ID: 3023511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E
    Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of platelet-derived growth factor from human platelets by arachidonic acid.
    Linder BL; Chernoff A; Kaplan KL; Goodman DS
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4107-11. PubMed ID: 291068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation and [14C] serotonin release by luciferin: luciferase preparations.
    Pfueller SL; Broadway M
    Thromb Res; 1986 Nov; 44(4):539-42. PubMed ID: 3798413
    [No Abstract]   [Full Text] [Related]  

  • 14. Aromatic tetra-amidines with antiproteolytic activity inhibit platelet aggregation and secretion.
    Milani L; Ferroni R; Zaccarini M; Traniello S
    Thromb Res; 1989 Nov; 56(3):417-24. PubMed ID: 2515612
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the effect of platelet inhibitors on platelet adhesion to collagen and collagen-induced human platelet activation.
    Krishnamurthi S; Kakkar VV
    Thromb Haemost; 1985 Jun; 53(3):337-42. PubMed ID: 4049308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1974 Nov; 77(2):135-49. PubMed ID: 4374890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditions influencing platelet lysis.
    Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
    Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.